[Common name] Amoxicillin Sodium and Clavulanate Potassium for Injection

[Ingredients] The product is a kind of compound preparation, containing 0.5g amoxicillin sodium (calculated on the basis of amoxicillin) and 0.1g clavulanate potassium (calculated on the basis of clavulanate) in each 0.6g of product; (2) containing 1.0g amoxicillin sodium (calculated on the basis of amoxicillin) and 0.2g clavulanate potassium (calculated on the basis of clavulanate) in each 1.2g of product; the ratio of amoxicillin to clavulanate is 5:1.

[Indication] Upper respiratory tract infection, lower respiratory tract infection, urinary system infection, skin and soft tissue infection, and other infections

[Specification] （1）0.6g（C16H19N3O5S 0.5g与C8H9NO5 0.1g）（2）1.2g（C16H19N3O5S 1.0g与C8H9NO5 0.2g）

[Usage and Dosage] Intravenous injection or drip; For adult, 1.2g at each time, 3-4 times a day, a 10～14 -day course; For children, the dosage shall be calculated on the basis of 30mg/kg, 3～4 times a day (2～3 times a day for newborn) Allow the product with specified amount dissolve in 50～100m l0.9% sodium chloride injection, 30min intravenous drip.

[Package] Penicillin bottle packaging, 10 bottles per box.

[Expiry Date] 24 months

[Executive Standard] Chinese Pharmacopoeia, Version 2010, Vol. II

[Approval Document Number] (1) 0.6g: G (J) H20058833 (2) 1.2g: G (J) H20058966